Time to treatment benefit for adult patients with Fabry disease receiving agalsidase β: data from the Fabry Registry

Time to treatment benefit for adult patients with Fabry disease receiving agalsidase β: data from the Fabry Registry

Bibliographic Details
Main Authors: Ortiz, Alberto, Abiose, Ademola, Bichet, Daniel G, Cabrera, Gustavo, Charrow, Joel, Germain, Dominique P, Hopkin, Robert J, Jovanovic, Ana, Linhart, Aleš, Maruti, Sonia S, Mauer, Michael, Oliveira, João P, Patel, Manesh R, Politei, Juan, Waldek, Stephen, Wanner, Christoph, Yoo, Han-Wook, Warnock, David G
Format: Online
Language:English
Published: BMJ Publishing Group 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941144/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941144/

Similar Items